Observe Intestinal Tract Cleaness of Senile Constipation Patients Used Gastrointestinal External Stimulation
A Prospective, Randomized, Double-blind Controlled Clinical Study of Observation the Effect of Gastrointestinal External Stimulation on Intestinal Tract Cleaness in Patients With Senile Constipation
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a prospective, randomized, double-blind controlled trial. Elderly patients with constipation requiring colonoscopy were randomly divided into four groups: 1. Received both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation; 2. Received gastrointestinal external stimulation singly; 3. Received transcutaneouselectrical acupoint stimulation singly; 4. No stimulation was given. All groups received oral administration of polyethylene glycol for intestinal cleansing. Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedMay 16, 2024
May 1, 2024
1.2 years
January 30, 2024
May 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Boston Bowel Preparation Scale (BBPS)
Boston Bowel Preparation Scale (BBPS) score was used to assess the quality of intestinal cleanliness , with a total score of 9, and higher scores indicating better intestinal cleanliness, and BBPS≥6 was defined effective.
1 year
The positive rate of intestinal diseases
The positive rate of intestinal diseases including polyps, adenoma, adenocarcinoma, enteritis, inflammatory bowel disease,diverticulum and so on by electronic colonoscopy.
1 year
Secondary Outcomes (4)
Adverse reactions
1 year
Willingness to repeat
1 year
Gut microbiome alterations
1 year
Gastrointestinal hormone
1 year
Study Arms (4)
experimental group 1
EXPERIMENTALReceived both gastrointestinal external stimulation and transcutaneouselectrical acupoint stimulation for 3 days, and then oral administration of polyethylene glycol for intestinal cleansing.
experimental group 2
EXPERIMENTALReceived gastrointestinal external stimulation singly, and then oral administration of polyethylene glycol for intestinal cleansing.
experimental group 3
EXPERIMENTALReceived transcutaneouselectrical acupoint stimulation singly, and then oral administration of polyethylene glycol for intestinal cleansing.
Control
NO INTERVENTIONNo stimulation was given. Oral administration of polyethylene glycol for intestinal cleansing.
Interventions
We used the device Gastrointestinal multifunctional therapeutic instrument. The positive pole was placed 1 to 2cm above the umbilicus, and the negative pole was placed 4 to 10 cm to the right of the midpoint between the xiphoid process and the umbilicus.
Eligibility Criteria
You may qualify if:
- Age 60-80 years old;
- Colonoscopy was planned;
- The diagnosis of constipation was in accordance with Rome Ⅳ criteria.
You may not qualify if:
- Acute myocardial infarction (within 6 months), severe heart failure (New York Heart Association class II-V, chronic renal failure (CKD stage II-V), or mental disorder;
- Colorectal resection;
- Drugs of aspirin, warfarin, or other anticoagulants, and coagulopathy;
- Oral administration any drugs that may affect gastrointestinal motility, such as proton pump inhibitors, non-steroidal anti-inflammatory drugs or antibiotics (within 4 weeks), probiotics (within 2 weeks);
- The following diseases:inflammatory bowel disease, frequent diarrhea, severe gastroparesis, intestinal perforation or obstruction;
- Participating in other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai easthospital
Shanghai, Pudong New Area, 200120, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The Participants, investigators and outcomes Assessor don't know receiverd which intervention, only care Providers know it.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2024
First Posted
May 16, 2024
Study Start
February 1, 2024
Primary Completion
March 31, 2025
Study Completion
May 31, 2025
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share